Evoke Pharma, Inc. (EVOK)

$3.87 4.03% $0.15 Healthcare

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

$3.17M

Mr. David A. Gonyer R.Ph.

4.00

Solana Beach, CA

Sep 25, 2013

0.03

$116.88

1.08

1.39

-116.76%

-0.63

-0.04

1.28

0.69

1.25

-57.24%

-4,897.74%

Similar stocks (9)

Aquestive Therapeutics, Inc.

AQST

$4.18 -1.18%
Uptrend

Journey Medical Corporation

DERM

$4.68 -0.43%
Downtrend

Eagle Pharmaceuticals, Inc.

EGRX

$4.25 -3.19%
Downtrend

Cumberland Pharmaceuticals Inc.

CPIX

$1.30 0.39%
Downtrend

Guardion Health Sciences, Inc.

GHSI

$13.25 -0.75%
Uptrend

Agile Therapeutics, Inc.

AGRX

$1.51 0.00%
Uptrend

Biofrontera Inc.

BFRI

$1.11 -0.89%
Downtrend

Shuttle Pharmaceuticals Holdings, Inc.

SHPH

$1.63 -24.88%
Downtrend

Petros Pharmaceuticals, Inc.

PTPI

$0.34 5.56%
Downtrend

ETF Exposure (9)

iShares MSCI United Kingdom Small-Cap ETF

EWUS

0.0676%

$37.75 -1.83%
Uptrend

iShares MSCI Europe Small-Cap ETF

IEUS

0.02293%

$57.81 -1.73%
Neutral

iShares MSCI Intl Small-Cap Multifactor ETF

ISCF

0.01989%

$33.08 -2.01%
Neutral

iShares MSCI EAFE Small-Cap ETF

SCZ

0.01069%

$64.12 -2.00%
Uptrend

iShares Core MSCI International Developed Markets ETF

IDEV

0.00192%

$67.40 -1.78%
Uptrend

iShares Core MSCI Total International Stock ETF

IXUS

0.00173%

$68.28 -1.78%
Neutral

iShares Core MSCI EAFE ETF

IEFA

0.00149%

$74.28 -1.94%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$129.08 -1.69%
Neutral

Vanguard Extended Market Index Fund

VXF

0%

$170.15 -1.70%
Neutral